BioIntelliSense Closes Oversubscribed $45M Series B Financing Round to Scale Its Data-as-a-Service and Clinical Intelligence Platform

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3BReLw5
via IFTTT